We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Appellate Court Upholds Actavis’s Lo Loestrin FE Patent Against ANDAs
Appellate Court Upholds Actavis’s Lo Loestrin FE Patent Against ANDAs
Actavis’s birth control pill Lo Loestrin FE is safe from generic competition for the moment after a federal appeals court reaffirmed a lower court’s decision finding that ANDAs by generics makers Lupin and Amneal infringed the drug’s patent.